Home NDC 0299-6220 NEMLUVIO
Product NDC 0299-6220
11-digit product format 002996220
Labeler code 0299
Product ID 0299-6220_df0e2be2-b6bd-40e5-9175-0c8e893433ea
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name nemolizumab-ilto
Dosage form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route SUBCUTANEOUS
Labeler Galderma Laboratories, L.P.
Application BLA761390
Marketing category BLA
Marketing start 2024-08-13
Substance NEMOLIZUMAB
Active strength 30 mg/100mg
Pharmacologic classes Interleukin-31 Receptor alpha Antagonist [EPC], Interleukin-31 Receptor alpha Antagonists [MoA]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes openFDA label cross-check# Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Additional Listing Data#
Finished product Yes
Brand name base NEMLUVIO
Listing expiration 2026-12-31
Active Ingredients# Ingredient, Strength table Ingredient Strength NEMOLIZUMAB 30 mg/100mg
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination GN465U8B72 Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 2691325 Internal RxNorm lookup 2691328 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 0299-6220-10 NEMLUVIO 30 mg in 1 SYRINGE, GLASS INJECTION, POWDER, LYOPHILIZED, 30 5 0299-6220-10 NEMLUVIO 1 in 1 CARTON INJECTION, POWDER, LYOPHILIZED, 1 5 0299-6220-15 NEMLUVIO 1 in 1 CARTON INJECTION, POWDER, LYOPHILIZED, 1 5 0299-6220-15 NEMLUVIO 30 mg in 1 SYRINGE INJECTION, POWDER, LYOPHILIZED, 30 5
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 0299-6220 NEMLUVIO (NEMOLIZUMAB-ILTO) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [GALDERMA LABORATORIES, L.P.] 3 Current NDC, 4 package rows 20250507_e9229ef1-ac60-4c24-afb6-009d3c781687.zip
Purple Book Biologic Products# BLA, Proprietary name, Proper name table BLA Proprietary name Proper name License type Status Latest source 761390 Nemluvio nemolizumab-ilto 351(a) Rx 2026-06-01
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Sample Exclude flag Status 0299-6220-10 00299622010 1 SYRINGE, GLASS in 1 CARTON (0299-6220-10) / 30 mg in 1 SYRINGE, GLASS 2024-08-13 Yes No Current 0299-6220-15 00299622015 1 SYRINGE in 1 CARTON (0299-6220-15) / 30 mg in 1 SYRINGE 1 syringe 2024-08-13 No No Current